Kikuchi M, Itakura A, Miki A, et al: Fibrinogen concentrate substitution therapy for obstetric hemorrhage complicated by coagulopathy. ] Obstet Gynaecol Res 0,n2013 King DL: Placental migration demonstrated by ultrasonography. Radiology 109:167, 1973 Klar M, Michels KB: Cesarean section and placental disorders in subsequent pregnancies-a meta-analysis.n] Perinat Med 42(5):571,n2014 Knight , Berg C, Brocklehurst P, et al: Amniotic luid embolism incidence, risk factors and outcomes: a review and recommendations. BMC Pregnancy Childbirth 12:7,n2012 Knight M, Tufnell 0, Brocklehurst P, et al: Incidence and risk factors for amniotic-fluid embolism. Obstet Gynecol 115(5):910,n2010 Knight M, UKOSS: Peripartum hysterectomy in the UK: management and outcomes of the associated haemorrhage. B]OG 114:1380,n2007 Koen S, Synman LC, Pattinson RC, et al: A randomised controlled trial comparing oxytocin and oxytocin +ergotamine for prevention of postpartum hemorrhage at caesarean section. S Afr Med] 106:55,2016 Kohari KS, Roman AS, Fox NS, et al: Persistence of placenta previa in rwin gestations based on gestational age at sonographic detection. ] Ultrasound Med 31(7):985,n2012 Kollmann M, Gaulhofer], Lang U, et al: Placenta previa: incidence, risk factors and outcome.n] Maten Fetal Neonatal Med 29(9):1395, 2016 Kolomeyevskaya NV, Tanyi ]L, Coleman NM, et al: Balloon tamponade of hemorrhage after uterine curettage for gestational trophoblastic disease. Obstet Gynecol 113:557,2009
Kotsuji F, Nishihima K, Kurokawa T, et al: Transverse uterine fundal incision for placenta praeyia with accreta, involving the entire anterior uterine wall: a case series. B]OG 120(9):1144,n2013
Kramer MS, Berg C, Abenhaim H, et 1: Incidence, risk factors, and temporal trends in severe postpartum hemorrhage. Am] Obstet GynecoI209(5):449.el, 2013 Kramer MS, Rouleau ], Liu 5, et al: Amniotic fluid embolism: incidence, risk factors, and impact on perinatal outcomes. B]OG 4,n2012
KUCZYI1Skin], Uszynski W, Zekanowska E, et al: Tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in the placenta and myometrium. Eur ] Obstet Gynecol Reprod Bioi 105: 15, 2002
Kumru P, Demirci 0, Erdogdu E, et al: The Bakri balloon for the management of postpartum hemorrhage in cases with placenta previa. Eurn] Obstet Gynecol Reprod Bioi (2):167,n2013
Kuriya A, Piedimonte 5, Spence AR, et al: Incidence and causes of matenal mortality in the USA.n] Obstet Gynaecol Res 42(6):661,n2016